|Articles|March 14, 2023

Mural Health and ProofPilot Partner Patient Payments

Agreement expected to upgrade customer payments.

Mural Health, provider of participant management platform Mural Link, announced it will join ProofPilot’s digital protocol automation platform as a partner to improve participant payments.

“At ProofPilot, we have always seen a higher degree of patient compliance when payments can be automated and closely tied to a wide variety of tasks. Most are unaware of the number of hidden activities needed for a patient to execute during a study outside of the explicit tasks,” said Chris Venezia, CEO of ProofPilot. “Through the strategic partnership of our digital protocol automation platform, along with Mural Health’s participant payment capabilities, we will make it easier for our sites and patients to successfully conduct and participate in research by increasing the efficiency to complete tasks, procedures, and now, patient payments.”

Reference: Mural Health and ProofPilot Partner to Streamline Payments and Provide More Patient Choice. Berwyn, PA and New York, NY, USA, MARCH 14, 2023.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related to this article

November 4th, 2026

Comparing OpenAI and Mistral on Clinical Trial Matching

Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.

November 4th, 2026

The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time

In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.

November 4th, 2026

ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal

In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.

© putilov_denis - © putilov_denis - stock.adobe.com

November 3rd, 2026

From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA

Neuroscience trials struggle to show benefit because symptoms are subjective and variable, and eCOA strengthens dossiers by standardizing ClinRO administration, capturing outcomes in real time to reduce recall bias, and adding patient and caregiver perspectives that clinician scales miss.

© flashmovie - © flashmovie - stock.adobe.com

November 3rd, 2026

Beyond the Modernization Act: What It Takes to Make Community Research Infrastructure Permanent

Community participation gaps look less like a question of patient willingness and more like a financing and infrastructure problem that no single bill has yet solved.

November 3rd, 2026

ACT Brief: Embedding AI Across Operations, Faster Trial Decisions, and Voceryq Approval

In today’s ACT Brief, we examine what changes when AI is embedded across clinical operations, why faster trial data isn’t yet producing faster decisions, and how FDA granted accelerated approval to a therapy for a rare airway disease.

© Sergey Nivens - © Sergey Nivens - stock.adobe.com

November 2nd, 2026

From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions

Data capture is no longer the bottleneck, and whether the lag between a signal and a decision shrinks depends on signal design, AI governance, and vendor orchestration.

November 2nd, 2026

Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health

In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses what changes when AI is embedded across protocol strategy, data infrastructure, and workflow tools at once, where governance frameworks tend to fall short, and why CROs must orchestrate AI ecosystems rather than simply aggregate them.